SG11202002965WA - Psma ligands for imaging and endoradiotherapy - Google Patents
Psma ligands for imaging and endoradiotherapyInfo
- Publication number
- SG11202002965WA SG11202002965WA SG11202002965WA SG11202002965WA SG11202002965WA SG 11202002965W A SG11202002965W A SG 11202002965WA SG 11202002965W A SG11202002965W A SG 11202002965WA SG 11202002965W A SG11202002965W A SG 11202002965WA SG 11202002965W A SG11202002965W A SG 11202002965WA
- Authority
- SG
- Singapore
- Prior art keywords
- endoradiotherapy
- imaging
- psma ligands
- psma
- ligands
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nuclear Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17206510 | 2017-12-11 | ||
| PCT/EP2018/084399 WO2019115547A1 (en) | 2017-12-11 | 2018-12-11 | Psma ligands for imaging and endoradiotherapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202002965WA true SG11202002965WA (en) | 2020-04-29 |
Family
ID=60654872
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202002965WA SG11202002965WA (en) | 2017-12-11 | 2018-12-11 | Psma ligands for imaging and endoradiotherapy |
Country Status (34)
| Country | Link |
|---|---|
| US (2) | US11497819B2 (sl) |
| EP (3) | EP3723815B1 (sl) |
| JP (3) | JP7317375B2 (sl) |
| KR (1) | KR102815791B1 (sl) |
| CN (2) | CN116617421A (sl) |
| AU (2) | AU2018382479B2 (sl) |
| BR (1) | BR112020011727A2 (sl) |
| CA (1) | CA3078104A1 (sl) |
| CL (1) | CL2020001542A1 (sl) |
| CR (1) | CR20200241A (sl) |
| CU (1) | CU24677B1 (sl) |
| CY (1) | CY1125376T1 (sl) |
| DK (2) | DK4008359T3 (sl) |
| EC (1) | ECSP20029142A (sl) |
| ES (2) | ES2997266T3 (sl) |
| FI (1) | FI4008359T3 (sl) |
| HR (2) | HRP20220764T1 (sl) |
| HU (2) | HUE059083T2 (sl) |
| IL (3) | IL313103B2 (sl) |
| JO (1) | JOP20200135A1 (sl) |
| LT (2) | LT4008359T (sl) |
| MX (2) | MX2020005430A (sl) |
| NZ (1) | NZ763033A (sl) |
| PE (1) | PE20210456A1 (sl) |
| PL (1) | PL3723815T3 (sl) |
| PT (2) | PT4008359T (sl) |
| RS (2) | RS66086B1 (sl) |
| SG (1) | SG11202002965WA (sl) |
| SI (2) | SI4008359T1 (sl) |
| SM (1) | SMT202400439T1 (sl) |
| TN (1) | TN2020000072A1 (sl) |
| UA (1) | UA126413C2 (sl) |
| WO (1) | WO2019115547A1 (sl) |
| ZA (1) | ZA202003472B (sl) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4000640A1 (en) * | 2017-07-28 | 2022-05-25 | Technische Universität München | Dual mode radiotracer and therapeutic |
| BR112020011727A2 (pt) | 2017-12-11 | 2020-11-17 | Technische Universität München | ligantes de psma para imageamento e endorradioterapia |
| CN113573743B (zh) * | 2019-01-30 | 2023-11-07 | 慕尼黑工业大学 | 癌症诊断成像剂 |
| HUE069264T2 (hu) * | 2019-01-30 | 2025-02-28 | Univ Muenchen Tech | Radio-nyomkövetõ és terápiás PSMA kötõ duális eljárás |
| CN114401947B (zh) | 2019-06-21 | 2024-11-29 | 省卫生服务机构 | 靶向前列腺特异性膜抗原的放射性标记化合物 |
| CN112321673B (zh) * | 2020-11-04 | 2022-09-20 | 北京市肿瘤防治研究所 | 一种前列腺特异性膜抗原靶向抑制剂及应用和探针 |
| CN113354707A (zh) * | 2021-06-07 | 2021-09-07 | 苏州思萃同位素技术研究所有限公司 | 一种针对前列腺癌的三功能诊疗一体化药物前体的合成方法及其产品 |
| WO2023173074A2 (en) * | 2022-03-10 | 2023-09-14 | The Research Foundation For The State University Of New York | Immunostimulant-cytotoxic conjugate composition and methods for cancer treatment |
| CN115010629B (zh) * | 2022-06-07 | 2024-02-23 | 西南医科大学附属医院 | 前列腺特异性膜抗原抑制剂、其核素标记物及制法和应用 |
| WO2025022285A2 (en) | 2023-07-21 | 2025-01-30 | Novartis Ag | Psma-targeting radioligand treatment regimen |
| WO2025029963A1 (en) | 2023-07-31 | 2025-02-06 | Curium Us Llc | [ 177lu] lutetium-psma i&t composition and dosimetry, kit, method of making, and method of using thereof |
| WO2025147677A1 (en) * | 2024-01-05 | 2025-07-10 | Point Biopharma, Inc. | Preparation of psma-targeted radiopharmaceutical |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200716632A (en) | 2005-05-16 | 2007-05-01 | Gilead Sciences Inc | Integrase inhibitor compounds |
| CN113563262A (zh) * | 2008-08-01 | 2021-10-29 | 约翰.霍普金斯大学 | Psma-结合剂及其用途 |
| WO2010135431A2 (en) * | 2009-05-19 | 2010-11-25 | The Regents Of The University Of California | Compositions, devices, and methods related to prostate-specific membrane antigen |
| DK4095130T3 (da) * | 2013-10-18 | 2024-04-22 | Novartis Ag | Mærkede hæmmere af prostataspecifikt membranantigen (psma), deres anvendelse som billeddannelsesmidler og farmaceutiske midler til behandling af prostatacancer |
| ES2743482T3 (es) * | 2014-05-06 | 2020-02-19 | Univ Johns Hopkins | Inhibidores de PSMA marcados con metal/radiometal para obtención de imágenes dirigidas a PSMA y radioterapia |
| US10688200B2 (en) | 2015-12-31 | 2020-06-23 | Five Eleven Pharma Inc. | Urea-based prostate specific membrane antigen (PSMA) inhibitors for imaging and therapy |
| RS62274B1 (sr) * | 2016-03-22 | 2021-09-30 | Univ Johns Hopkins | Sredstva sa visokim afinitetom za ciljano dejstvo na membranski antigen specifičan za prostatu za endoradioterapiju kancera prostate |
| BR112020011727A2 (pt) | 2017-12-11 | 2020-11-17 | Technische Universität München | ligantes de psma para imageamento e endorradioterapia |
| TW201930265A (zh) | 2017-12-11 | 2019-08-01 | 西班牙商阿爾米雷爾有限公司 | 作為acc抑制劑的吡咯衍生物 |
| EP3724176B1 (en) | 2017-12-11 | 2022-01-26 | Helsinn Healthcare SA | Fumarate salt of (r)-3-(1-(2,3-dichloro-4-(pyrazin-2-yl)phenyl)-2,2,2-trifluoroethyl)-1-methyl-1-(1-methylpiperidin-4-yl) urea, methods of preparation, and uses thereof |
-
2018
- 2018-12-11 BR BR112020011727-7A patent/BR112020011727A2/pt unknown
- 2018-12-11 RS RS20241176A patent/RS66086B1/sr unknown
- 2018-12-11 TN TNP/2020/000072A patent/TN2020000072A1/en unknown
- 2018-12-11 PT PT212181804T patent/PT4008359T/pt unknown
- 2018-12-11 EP EP18812215.4A patent/EP3723815B1/en active Active
- 2018-12-11 LT LTEP21218180.4T patent/LT4008359T/lt unknown
- 2018-12-11 SI SI201831155T patent/SI4008359T1/sl unknown
- 2018-12-11 DK DK21218180.4T patent/DK4008359T3/da active
- 2018-12-11 SM SM20240439T patent/SMT202400439T1/it unknown
- 2018-12-11 WO PCT/EP2018/084399 patent/WO2019115547A1/en active IP Right Grant
- 2018-12-11 HR HRP20220764TT patent/HRP20220764T1/hr unknown
- 2018-12-11 PL PL18812215.4T patent/PL3723815T3/pl unknown
- 2018-12-11 JP JP2020526146A patent/JP7317375B2/ja active Active
- 2018-12-11 EP EP21218180.4A patent/EP4008359B1/en active Active
- 2018-12-11 SI SI201830691T patent/SI3723815T1/sl unknown
- 2018-12-11 HU HUE18812215A patent/HUE059083T2/hu unknown
- 2018-12-11 HU HUE21218180A patent/HUE069034T2/hu unknown
- 2018-12-11 DK DK18812215.4T patent/DK3723815T3/da active
- 2018-12-11 CN CN202310801735.3A patent/CN116617421A/zh active Pending
- 2018-12-11 IL IL313103A patent/IL313103B2/en unknown
- 2018-12-11 PE PE2020000552A patent/PE20210456A1/es unknown
- 2018-12-11 CA CA3078104A patent/CA3078104A1/en active Pending
- 2018-12-11 PT PT188122154T patent/PT3723815T/pt unknown
- 2018-12-11 IL IL274072A patent/IL274072B2/en unknown
- 2018-12-11 HR HRP20241453TT patent/HRP20241453T1/hr unknown
- 2018-12-11 FI FIEP21218180.4T patent/FI4008359T3/fi active
- 2018-12-11 ES ES21218180T patent/ES2997266T3/es active Active
- 2018-12-11 JO JOP/2020/0135A patent/JOP20200135A1/ar unknown
- 2018-12-11 LT LTEPPCT/EP2018/084399T patent/LT3723815T/lt unknown
- 2018-12-11 RS RS20220527A patent/RS63279B1/sr unknown
- 2018-12-11 KR KR1020207014036A patent/KR102815791B1/ko active Active
- 2018-12-11 ES ES18812215T patent/ES2914832T3/es active Active
- 2018-12-11 CN CN201880056196.2A patent/CN111182927B/zh active Active
- 2018-12-11 CR CR20200241A patent/CR20200241A/es unknown
- 2018-12-11 SG SG11202002965WA patent/SG11202002965WA/en unknown
- 2018-12-11 EP EP24198677.7A patent/EP4464341A3/en active Pending
- 2018-12-11 UA UAA202003533A patent/UA126413C2/uk unknown
- 2018-12-11 NZ NZ763033A patent/NZ763033A/en unknown
- 2018-12-11 US US16/765,729 patent/US11497819B2/en active Active
- 2018-12-11 IL IL319022A patent/IL319022A/en unknown
- 2018-12-11 AU AU2018382479A patent/AU2018382479B2/en active Active
- 2018-12-11 MX MX2020005430A patent/MX2020005430A/es unknown
- 2018-12-11 CU CU2020000052A patent/CU24677B1/es unknown
-
2020
- 2020-06-03 EC ECSENADI202029142A patent/ECSP20029142A/es unknown
- 2020-06-10 ZA ZA2020/03472A patent/ZA202003472B/en unknown
- 2020-06-10 CL CL2020001542A patent/CL2020001542A1/es unknown
- 2020-07-13 MX MX2023005053A patent/MX2023005053A/es unknown
-
2022
- 2022-07-15 US US17/866,034 patent/US20230122957A1/en active Pending
- 2022-07-20 CY CY20221100496T patent/CY1125376T1/el unknown
-
2023
- 2023-07-11 JP JP2023113523A patent/JP7572080B2/ja active Active
-
2024
- 2024-10-03 JP JP2024173980A patent/JP2025011169A/ja active Pending
-
2025
- 2025-02-07 AU AU2025200837A patent/AU2025200837A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202003472B (en) | Psma ligands for imaging and endoradiotherapy | |
| AU201614482S (en) | Shakers | |
| GB201701593D0 (en) | Imaging apparatus | |
| IL255931B (en) | Image device | |
| GB201712357D0 (en) | Spetral imaging | |
| PL3420150T3 (pl) | Urządzenie sitowe | |
| GB2561441B (en) | Connection apparatus | |
| GB201609747D0 (en) | Data directed desi-ms imaging | |
| GB201711617D0 (en) | Cover apparatus | |
| GB201607456D0 (en) | Imaging unit | |
| GB201819514D0 (en) | Connection apparatus | |
| PL3718435T3 (pl) | Zespół ślizgowy | |
| PL3593208T3 (pl) | Urządzenie do fotografowania obiektów | |
| GB201705679D0 (en) | Imaging agent | |
| HK40031508A (en) | Psma ligands for imaging and endoradiotherapy | |
| GB201517277D0 (en) | Imaging device | |
| GB201816607D0 (en) | Light-sheet imaging | |
| GB201705653D0 (en) | Methods and means for imaging | |
| GB201714175D0 (en) | An imaging device | |
| GB201722155D0 (en) | Grills | |
| GB201719957D0 (en) | Instamatic cameras | |
| GB201718522D0 (en) | T | |
| GB201622333D0 (en) | Smartphone screen cover | |
| GB201705258D0 (en) | Imaging agent | |
| GB201611180D0 (en) | Imaging apparatus |